Authors reported that patients administered oral THC experienced a “nine-fold greater reduction in opioid consumption” compared to controls.
Rather than use these unfortunate incidents as an opportunity to further drive these markets into the shadows, the administration should officially legalize cannabis and empower the FDA to better study, regulate, and oversee these emerging THC and CBD delivery devices — and to create regulatory standards for legal states to follow and enforce.
Drivers testing positive for the presence of THC in blood do not possess a significantly increased risk of being responsible for a non-fatal motor vehicle accident, according to data published in the journal Addiction.
Republican Gov. Brian Kemp signed legislation into law today to facilitate regulations governing the licensed production and distribution of oils and other products containing limited amounts of plant-derived THC.
A growing coalition of NORML Chapters in California, Oregon, Colorado and Washington have come together to advocate for necessary legislative and workplace reforms to protect responsible marijuana consumers from discriminatory practices such as workplace drug testing.
For almost 45 years, NORML chapters have been the driving force behind policy decisions regarding marijuana on the local, state level and federal level. Get involved today!
The administration of oral THC mitigates symptoms of post-traumatic stress syndrome (PTSD), according to clinical trial data published online ahead of print in the journal Clinical Drug Investigation. Researchers reported, “The intervention caused a statistically significant improvement in global symptom severity, sleep quality, frequency of nightmares, and PTSD hyperarousal symptoms.” They concluded, “Orally absorbable delta-9-THC was safe and well tolerated by patients with chronic PTSD.”
Most of us were caught off-guard by the rush of states this year that approved…